Filtered By:
Infectious Disease: Outbreaks
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 348 results found since Jan 2013.
Neuropsychological adverse drug reactions of Remdesivir: analysis using VigiBase, the WHO global database of individual case safety reports
CONCLUSIONS: Our study demonstrates that remdesivir, a novel drug applied to the treatment of COVID-19, does not have a significant association with adverse neurologic or psychiatric reactions in the real-world setting.PMID:34919240 | DOI:10.26355/eurrev_202112_27435
Source: Pharmacological Reviews - December 17, 2021 Category: Drugs & Pharmacology Authors: S Lee J W Yang S Y Jung M S Kim D K Yon S W Lee H-C Kang E Dragioti K Tizaoui L Jacob A Koyanagi J-E Salem K Kostev A Lascu J I Shin J H Kim L Smith Source Type: research
Effects of an Infection Control Protocol for Coronavirus Disease in Emergency Mechanical Thrombectomy
CONCLUSION: The COVID-19 protection protocol significantly impacted the door-to-imaging time. Shortening the door-to-imaging time and performing the procedure under local anesthesia, if possible, may be required to reduce the door-to-puncture and doorto- recanalization times. The effect of various aspects of the protection protocol on emergency thrombectomy should be further studied.PMID:34879638 | DOI:10.3340/jkns.2021.0053
Source: Journal of Korean Neurosurgical Society - December 9, 2021 Category: Neurosurgery Authors: Jin Eun Min-Hyung Lee Sang-Hyuk Im Won-Il Joo Jae-Geun Ahn Do-Sung Yoo Hae-Kwan Park Source Type: research
